Marion Odence-Ford - 11 Feb 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
General Counsel and CCO
Signature
/s/ Marion K. Odence-Ford
Issuer symbol
OPRX
Transactions as of
11 Feb 2025
Transactions value $
$-7,762
Form type
4
Filing time
13 Feb 2025, 15:58:00 UTC
Previous filing
27 Dec 2024
Next filing
20 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Options Exercise +4,000 +5.83% 72,638 11 Feb 2025 Direct F1
transaction OPRX Common Stock Tax liability $-7,762 -1,386 -1.91% $5.60 71,252 11 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Options Exercise $0 -4,000 -25% $0.000000 12,000 11 Feb 2025 Common Stock 4,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
F3 On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.